Grewal I S, Foellmer H G, Grewal K D, Xu J, Hardardottir F, Baron J L, Janeway C A, Flavell R A
Howard Hughes Medical Institute, and Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.
Science. 1996 Sep 27;273(5283):1864-7. doi: 10.1126/science.273.5283.1864.
The mechanism of CD40 ligand (CD40L)-mediated in vivo activation of CD4(+) T cells was examined by investigation of the development of experimental allergic encephalomyelitis (EAE) in CD40L-deficient mice that carried a transgenic T cell receptor specific for myelin basic protein. These mice failed to develop EAE after priming with antigen, and CD4(+) T cells remained quiescent and produced no interferon-gamma (IFN-gamma). T cells were primed to make IFN-gamma and induce EAE by providing these mice with B7.1(+) antigen-presenting cells (APCs). Thus, CD40L is required to induce costimulatory activity on APCs for in vivo activation of CD4(+) T cells to produce IFN-gamma and to evoke autoimmunity.
通过研究携带针对髓鞘碱性蛋白的转基因T细胞受体的CD40配体(CD40L)缺陷小鼠实验性自身免疫性脑脊髓炎(EAE)的发展,来检测CD40L介导的体内CD4(+) T细胞激活机制。用抗原引发后,这些小鼠未能发展出EAE,并且CD4(+) T细胞保持静止,不产生干扰素-γ(IFN-γ)。通过为这些小鼠提供B7.1(+)抗原呈递细胞(APC),T细胞被引发产生IFN-γ并诱导EAE。因此,CD40L是在体内激活CD4(+) T细胞以产生IFN-γ并引发自身免疫所需的,用于诱导APC上的共刺激活性。